Luye Pharma Group has announced submission of a NDA to the U S FDA for Rykindo®
The company has enacted a multi-faceted development plan for sales, R&D, M&A and external collaborations, not ...
The Sentosa® SQ HIV Genotyping Assay is intended for the detection of HIV-1 Group M genomic drug resistance mu...
Luye Pharma’s new drug LY03010 for the treatment of schizophrenia and schizoaffective disorders has obtained ...
Luye Pharma has announced the acquisition of two investigational biological antibodies being developed by Shan...
Luye Pharma grants AstraZeneca exclusives rights to promote Xuezhikang Capsules in mainland China
TOP